[Management of acute leukemias and linphosarcomas with active immunotherapy (author's transl)].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use*; D003352:Corynebacterium; D004359:Drug Therapy, Combination; D006801:Humans; D007167:Immunotherapy; D007945:Leukemia, Lymphoid / Q000628:therapy*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D011425:Propionibacterium acnes
D000970:Antineoplastic Agents; D001500:BCG Vaccine
INMUNOTERAPIA ACTIVA DE LAS LEUCEMIAS AGUDAS Y LINFOSARCOMAS